Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and ...

Novo Nordisk A/S (NYSE: NVO) is one of the high-margin pharma stocks to buy now. Berenberg has reaffirmed its Hold rating on ...